The purpose of this special notice is to in accordance with FAR 6.305 (b) to post a redacted Justification and Approval for Other Than Full and Open Competition.
Contract Number 75A50119C00059 was awarded to Ridgeback Biotherapeutics as a Letter contract for the Research and Development Manufacture of mAb114 for Ebola in accordance with FAR Part 6.302-2 Unusual and Compelling Urgency.